₹805.15 10.15 (1.28%)
14:45 PM, 4-Mar-2025BSE : 524816
NSE : NATCOPHARM
Sector : Health care
ISIN Code : INE987B01026
Last Updated: 04-Mar-2025 | 02:45 PM IST
Market Cap (₹ Cr) | 14,420 |
Traded Value (₹ Cr) | 2.53 |
Volume (Shares) | 31,453 |
Face Value (₹) | 2 |
52-Week High (₹) | 1,638.35 |
52-Week High Date | 12-Sep-2024 |
52-Week Low (₹) | 757.75 |
52-Week Low Date | 28-Feb-2025 |
All Time High (₹) | 1,638.35 |
All Time High Date | 12-Sep-2024 |
All Time Low (₹) | 1.60 |
All Time Low Date | 17-Sep-2001 |
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr) | 14,420 |
EPS - TTM (₹) [C] | 104.13 |
P/E Ratio (X) [C] | 7.73 |
Face Value (₹) | 2 |
Latest Dividend (%) | 75.00 |
Latest Dividend Date | 18-Feb-2025 |
Dividend Yield (%) | 1.17 |
Book Value Share (₹) [C] | 399.19 |
P/B Ratio (₹) [C] | 2.02 |
Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
---|---|---|---|
Tata Equity P/E Fund-(IDCW-Trigger-Opt B-10%) | 130.40 | 16,92,000 | 1.75 |
Tata Equity P/E Fund - (IDCW-Trigger - Opt A - 5%) | 130.40 | 16,92,000 | 1.75 |
Tata Equity P/E Fund - Direct (G) | 130.40 | 16,92,000 | 1.75 |
Tata Equity P/E Fund - Dir(IDCW-Trigger-Opt A-5%) | 130.40 | 16,92,000 | 1.75 |
Tata Equity P/E Fund - Dir(IDCW-Trigger-Opt B-10%) | 130.40 | 16,92,000 | 1.75 |
Tata Equity P/E Fund - (G) | 130.40 | 16,92,000 | 1.75 |
Tata Small Cap Fund - Direct (G) | 42.32 | 5,49,064 | 0.51 |
Tata Small Cap Fund - Direct (IDCW) RI | 42.32 | 5,49,064 | 0.51 |
Tata Small Cap Fund - Regular (IDCW) RI | 42.32 | 5,49,064 | 0.51 |
Tata Small Cap Fund - Direct (IDCW) | 42.32 | 5,49,064 | 0.51 |
Load more
Date | Broker | Action | Prices(₹) | Report |
---|---|---|---|---|
Data Not Found |
Today's Low/High (₹) | 781.00 814.80 |
Week Low/High (₹) | 502.00 814.80 |
Month Low/High (₹) | 502.00 814.80 |
Year Low/High (₹) | 757.75 1,638.00 |
All time Low/High (₹) | 1.60 1,638.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | 50.51% | 50.47% | 22.97% | 25.45% |
1 Month | 42.87% | 43.08% | 19.03% | 21.13% |
3 Month | 29.21% | 29.28% | 19.93% | 22.34% |
6 Month | 7.40% | 7.53% | 25.04% | 27.01% |
1 Year | -11.71% | -11.63% | 24.11% | 25.77% |
3 Year | 28.89% | 28.97% | 82.98% | 88.64% |
Chairman & Managing Director : V C Nannapaneni
Non-Exec. & Independent Dir. : G S Murthy
Vice Chairman & CEO : Rajeev Nannapaneni
Non-Exec. & Independent Dir. : T V Rao
Non-Exec. & Independent Dir. : D G Prasad
Non-Exec. & Independent Dir. : Leelaa Digumarti
Executive Director : PSRK Prasad
Non-Exec. & Independent Dir. : MUR Naidu
President & Director : D Linga Rao
Registered Office: Natco House, Road No 2 Banjara Hills,Hyderabad,Telangana-500033 Ph: 91-040-23547532
1. What's the Natco Pharma Ltd share price today?
Natco Pharma Ltd share price was Rs 805.15 at 14:45 PM IST on 4th Mar 2025. Natco Pharma Ltd share price was up by 1.28% over the previous closing price of Rs 795.00. Natco Pharma Ltd share price trend:
2. How can I quickly analyse the performance of the Natco Pharma Ltd stock?
The performance of the Natco Pharma Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Natco Pharma Ltd?
Natco Pharma Ltd has a market capitalisation of Rs 14,420 crore.
4. What is Natco Pharma Ltd's 52-week high/low share price?
The Natco Pharma Ltd’s 52-week high share price is Rs 1,638.35 and 52-week low share price is Rs 757.75.
5. Is the Natco Pharma Ltd profitable?
On a consolidated basis, Natco Pharma Ltd reported a profit of Rs 124.90 crore on a total income of Rs 575.60 crore for the quarter ended 2024. For the year ended Dec 2024, Natco Pharma Ltd had posted a profit of Rs 132.40 crore on a total income of Rs 651.10 crore.
6. Which are Natco Pharma Ltd’s peers in the Health care sector?
Natco Pharma Ltd’s top 5 peers in the Health care sector are Sai Life, Neuland Labs., Jubilant Pharmo, Natco Pharma, Caplin Point Lab, Blue Jet Health, Alivus Life.
7. Who owns how much in Natco Pharma Ltd?
Key changes to the Natco Pharma Ltd shareholding are as follows: